The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

The emerging hallmarks of cancer metabolism

Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · see citing works

Comprehensive molecular characterization of clear cell renal cell carcinoma

The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485 · see citing works

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331 · see citing works

Fundamentals of Cancer Metabolism

DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · see citing works

Understanding the Intersections between Metabolism and Cancer Biology

Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267 · see citing works

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works

From Krebs to clinic: glutamine metabolism to cancer therapy

Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119 · see citing works

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase

Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · see citing works

Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

Viswanathan, V. S., Ryan, M. J., Dhruv, H. D., Gill, S., Eichhoff, O. M., Seashore-Ludlow, B., Kaffenberger, S. D., Eaton, J. K., Shimada, K., Aguirre, A. J., et al. (2017) · Nature · doi:10.1038/nature23007 · Cited by 2,011 · see citing works

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990 · see citing works

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791 · see citing works

Mutations in <i>SDHD</i> , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma

Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · see citing works

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · see citing works

Nutrition Needs of Mammalian Cells in Tissue Culture

Eagle, H. (1955) · Science · doi:10.1126/science.122.3168.501 · Cited by 1,619 · see citing works

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462 · see citing works

HIF-1: upstream and downstream of cancer metabolism

Semenza, G. L. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,381 · see citing works

Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer

DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365 · see citing works

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336 · see citing works

Reductive carboxylation supports growth in tumour cells with defective mitochondria

Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328 · see citing works

Regulation of hepatic glucose metabolism in health and disease

Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,131 · see citing works

Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095 · see citing works

Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · see citing works

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer

Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068 · see citing works

Brick by brick: metabolism and tumor cell growth

DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics &amp; Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018 · see citing works

Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975 · see citing works

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · see citing works

Mutations in SDHC cause autosomal dominant paraganglioma, type 3

Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · see citing works

Molecular basis of the VHL hereditary cancer syndrome

Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865 · see citing works

The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

Davis, C., Ricketts, C. J., Wang, M., Yang, L., Cherniack, A. D., Shen, H., Buhay, C., Kang, H.-J., Kim, S. C., Fahey, C. C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.014 · Cited by 844 · see citing works

Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation

Wang, J.-B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L. B., Dias, S. M. G., Dang, C. V., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.009 · Cited by 821 · see citing works

Is Glutamine a Conditionally Essential Amino Acid?

Lacey, J. M., & Wilmore, D. W. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1990.tb02967.x · Cited by 808 · see citing works

An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

Hakimi, A. A., Reznik, E., Lee, C., Creighton, C. J., Brannon, A. R., Luna, A., Aksoy, B. A., Liu, E. M., Shen, R., Lee, W., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.004 · Cited by 791 · see citing works

The genetic basis of kidney cancer: a metabolic disease

Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.47 · Cited by 743 · see citing works

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · see citing works

Regulation of Glutaminase Activity and Glutamine Metabolism

Curthoys, N. P., & Watford, M. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.001025 · Cited by 643 · see citing works

The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type

Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639 · see citing works

Renal Gluconeogenesis

Gerich, J. E., Meyer, C., Woerle, H. J., & Stümvoll, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.382 · Cited by 602 · see citing works

Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

Timmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.020 · Cited by 573 · see citing works

Metabolic reprogramming in clear cell renal cell carcinoma

Wettersten, H. I., Aboud, O. A., Lara, P. N., & Weiss, R. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.59 · Cited by 573 · see citing works

Metabolism of amino-acids

Krebs, H. A. (1935) · Biochemical Journal · doi:10.1042/bj0291951 · Cited by 571 · see citing works

Fructose-1,6-bisphosphatase opposes renal carcinoma progression

Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535 · see citing works

Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1

Seltzer, M. J., Bennett, B. D., Joshi, A. D., Gao, P., Thomas, A. G., Ferraris, D. V., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Rabinowitz, J. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1666 · Cited by 513 · see citing works

Dynamic Analyses of Alternative Polyadenylation from RNA-Seq Reveal 3′-UTR Landscape Across 7 Tumor Types

Xia, Z., Donehower, L., Cooper, T., Neilson, J., Wheeler, D., Wagner, E., & Li, W. (2014) · Nature Communications · doi:10.1038/ncomms6274 · Cited by 509 · see citing works

Urea and Ammonia Metabolism and the Control of Renal Nitrogen Excretion

Weiner, I. D., Mitch, W. E., & Sands, J. M. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10311013 · Cited by 493 · see citing works

CFIm25 links alternative polyadenylation to glioblastoma tumour suppression

Masamha, C. P., Xia, Z., Yang, J., Albrecht, T. R., Li, M., Shyu, A., Li, W., & Wagner, E. J. (2014) · Nature · doi:10.1038/nature13261 · Cited by 449 · see citing works

The ever-expanding role of HIF in tumour and stromal biology

LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 432 · see citing works

Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis

Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427 · see citing works

Acid-Base Homeostasis

Hamm, L. L., Nakhoul, N. L., & Hering-Smith, K. S. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07400715 · Cited by 426 · see citing works

Oncometabolites: linking altered metabolism with cancer

Yang, M. H., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 424 · see citing works

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

Xiang, Y., Stine, Z. E., Xia, J., Lu, Y., O’Connor, R. S., Altman, B. J., Hsieh, A. L., Gouw, A. M., Thomas, A. G., Gao, P., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75836 · Cited by 409 · see citing works

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition

Jacque, N., Ronchetti, A. M., Larrue, C., Meunier, G., Birsen, R., Willems, L., Saland, E., Decroocq, J., Maciel, T. T., Lambert, M., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621870 · Cited by 387 · see citing works

Mitochondrial metabolism of glutamine and glutamate and its physiological significance.

Kovacevic, Z., & McGivan, J. D. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.2.547 · Cited by 374 · see citing works

The PI3K/AKT Pathway and Renal Cell Carcinoma

Guo, H., Germán, P., Bai, S., Barnes, S., Guo, W., Qi, X., Lou, H., Liang, J., Jonasch, E. W., Mills, G. B., et al. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.03.003 · Cited by 373 · see citing works

The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases

Kim, M., & Kim, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051051 · Cited by 371 · see citing works

Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes

Durinck, S., Stawiski, E. W., Pavía-Jiménez, A., Modrusan, Z. D., Kapur, P., Jaiswal, B. S., Zhang, N., Tcheuyap, V. T., Nguyen, T. T., Pahuja, K. B., et al. (2014) · Nature Genetics · doi:10.1038/ng.3146 · Cited by 357 · see citing works

Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements

Ramanathan, A., Wang, C., & Schreiber, S. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502267102 · Cited by 357 · see citing works

Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor

Killian, J. K., Kim, S. Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., Quezado, M., Smith, W. I., Jahromi, M. S., Xekouki, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0092 · Cited by 356 · see citing works

SIRT5 regulation of ammonia-induced autophagy and mitophagy

Polletta, L., Vernucci, E., Carnevale, I., Arcangeli, T., Rotili, D., Palmerio, S., Steegborn, C., Nowak, T., Schutkowski, M., Pellegrini, L., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1009778 · Cited by 350 · see citing works

Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)

Robinson, M. M., McBryant, S. J., Tsukamoto, T., Rojas, C. J., Ferraris, D. V., Hamilton, S. K., Hansen, J. C., & Curthoys, N. P. (2007) · Biochemical Journal · doi:10.1042/bj20070039 · Cited by 344 · see citing works

Hypoxic Regulation of Glutamine Metabolism through HIF1 and SIAH2 Supports Lipid Synthesis that Is Necessary for Tumor Growth

Sun, R. C., & Denko, N. C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.022 · Cited by 344 · see citing works

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer

Yang, L., Moss, T., Mangala, L. S., Marini, J., Zhao, H., Wahlig, S., Armaiz‐Pena, G., Jiang, D., Achreja, A., Win, J., et al. (2014) · Molecular Systems Biology · doi:10.1002/msb.20134892 · Cited by 326 · see citing works

In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation

Gameiro, P. A., Yang, J., Metelo, A. M., Pérez-Carro, R., Baker, R., Wang, Z., Arreola, A., Rathmell, W. K., Olumi, A., López-Larrubia, P., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.002 · Cited by 325 · see citing works

Targeting Glutamine Metabolism for Cancer Treatment

Choi, Y., & Park, K. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.178 · Cited by 321 · see citing works

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

Venneti, S., Dunphy, M. P., Zhang, H., Pitter, K. L., Zanzonico, P., Campos, C., Carlin, S., Rocca, G. L., Lyashchenko, S. K., Plöessl, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1009 · Cited by 314 · see citing works

Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis

Wettersten, H. I., Hakimi, A. A., Morin, D., Bianchi, C., Johnstone, M. E., Donohoe, D. R., Trott, J. F., Aboud, O. A., Stirdivant, S. M., Neri, B. P., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1703 · Cited by 295 · see citing works

Glutamine and Cancer

Souba, W. W. (1993) · Annals of Surgery · doi:10.1097/00000658-199312000-00004 · Cited by 294 · see citing works

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer

Hao, Y., Samuels, Y., Li, Q., Krokowski, D., Guan, B.-J., Wang, C., Jin, Z., Dong, B., Cao, B., Feng, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11971 · Cited by 290 · see citing works

Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism

Cassago, A., Ferreira, A. P. S., Ferreira, I. M., Fornezari, C., Gomes, E. R. M., Greene, K. S., Pereira, H. M., Garratt, R. C., Dias, S. M. G., & Ambrosio, A. L. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112495109 · Cited by 287 · see citing works

Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis

Cardaci, S., Zheng, L., MacKay, G., van den Broek, N. J. F., MacKenzie, E. D., Nixon, C., Stevenson, D., Tumanov, S., Bulusu, V., Kamphorst, J. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3233 · Cited by 286 · see citing works

Roles of glutamine in neurotransmission

Albrecht, J., Sidoryk-Węgrzynowicz, M., Zielińska, M., & Aschner, M. (2010) · Neuron Glia Biology · doi:10.1017/s1740925x11000093 · Cited by 273 · see citing works

MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism

Shroff, E. H., Eberlin, L. S., Dang, V. M., Gouw, A. M., Gabay, M., Adam, S. J., Bellovin, D. I., Tran, P. T., Philbrick, W. M., Garcia-Ocana, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507228112 · Cited by 255 · see citing works

Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health

Pochini, L., Scalise, M., Galluccio, M., & Indiveri, C. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00061 · Cited by 250 · see citing works

Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment

Tanaka, K., Sasayama, T., Irino, Y., Takata, K., Nagashima, H., Satoh, N., Kyotani, K., Mizowaki, T., Imahori, T., Ejima, Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78239 · Cited by 243 · see citing works

Metabolism and action of amino acid analog anti-cancer agents

Ahluwalia, G. S., Grem, J. L., Hao, Z., & Cooney, D. A. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90094-i · Cited by 241 · see citing works

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

Elgogary, A., Xu, Q., Poore, B., Alt, J., Zimmermann, S. C., Zhao, L., Fu, J., Chen, B., Xia, S., Liu, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611406113 · Cited by 234 · cited 7× · see citing works

Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism

Lussey-Lepoutre, C., Hollinshead, K. E. R., Ludwig, C., Menara, M., Morin, A., Castro-Vega, L.-J., Parker, S. J., Janin, M., Martinelli, C., Ottolenghi, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9784 · Cited by 227 · see citing works

Molecular Pathways: Fumarate Hydratase -Deficient Kidney Cancer—Targeting the Warburg Effect in Cancer

Linehan, W. M., & Rouault, T. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0304 · Cited by 223 · see citing works

Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species

Sudarshan, S., Sourbier, C., Kong, H.-S., Block, K., Romero, V. A. V., Yang, Y., Galindo, C., Mollapour, M., Scroggins, B., Goode, N., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00483-09 · Cited by 217 · see citing works

Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth

Cox, A. G., Hwang, K. L., Brown, K., Evason, K. J., Beltz, S., Tsomides, A., O’Connor, K., Galli, G. G., Yimlamai, D., Chhangawala, S., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3389 · Cited by 216 · see citing works

The Diverse Functions of Non-Essential Amino Acids in Cancer

Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213 · see citing works

The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels

Tong, W.-H., Sourbier, C., Kovtunovych, G., Jeong, S. Y., Vira, M., Ghosh, M., Romero, V. V., Sougrat, R., Vaulont, S., Viollet, B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.018 · Cited by 212 · see citing works

Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability

Ince-Dunn, G., Okano, H. J., Jensen, K. B., Park, W.-Y., Zhong, R., Ule, J., Mele, A., Fak, J. J., Yang, C., Zhang, C., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.009 · Cited by 212 · see citing works

Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids

Banerjee, S., Zare, R. N., Tibshirani, R. J., Kunder, C. A., Nolley, R., Fan, R. E., Brooks, J. D., & Sonn, G. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700677114 · Cited by 212 · see citing works

Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth

van den Heuvel, A. P. J., Jing, J., Wooster, R. F., & Bachman, K. E. (2012) · Cancer Biology &amp; Therapy · doi:10.4161/cbt.21348 · Cited by 209 · see citing works

Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism

Thangavelu, K., Pan, C. Q., Karlberg, T., Balaji, G., Uttamchandani, M., Suresh, V., Schüler, H., Low, B. C., & Sivaraman, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116573109 · Cited by 206 · see citing works

Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors

Shukla, K. H., Ferraris, D. V., Thomas, A. G., Stathis, M. J., Duvall, B. R., Delahanty, G., Alt, J., Rais, R., Rojas, C. J., Gao, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301191p · Cited by 199 · see citing works

Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing

Elgadi, K. M., Meguid, R. A., Qian, M. D., Souba, W. W., & Abcouwer, S. F. (1999) · Physiological Genomics · doi:10.1152/physiolgenomics.1999.1.2.51 · Cited by 195 · see citing works

HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival

Stegen, S., van Gastel, N., Eelen, G., Ghesquière, B., D’Anna, F., Thienpont, B., Goveia, J., Torrekens, S., Looveren, R. V., Luyten, F. P., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.002 · Cited by 187 · see citing works

Relevance of glutamine metabolism to tumor cell growth

Medina, M. Á., Sánchez‐Jiménez, F., Márquez, J., Quesada, A. R., & de Castro, I. N. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00230880 · Cited by 186 · see citing works

Famine versus feast: understanding the metabolism of tumors in vivo

Mayers, J. R., & Heiden, M. G. V. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.01.004 · Cited by 185 · see citing works

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes

Matre, P., Velez, J., Jacamo, R., Qi, Y., Su, X., Cai, T., Chan, S. M., Lodi, A., Sweeney, S. R., Ma, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12944 · Cited by 185 · see citing works

Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2

Redis, R. S., Vela, L. E., Lu, W., de Oliveira, J. F., Ivan, C., Rodriguez‐Aguayo, C., Adamóski, D., Pasculli, B., Taguchi, A., Chen, Y., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.015 · Cited by 182 · see citing works

Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells

Filipp, F. V., Scott, D. A., Ronai, Z. A., Osterman, A. L., & Smith, J. W. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00989.x · Cited by 181 · see citing works

A Tale of Two Glutaminases: Homologous Enzymes with Distinct Roles in Tumorigenesis

Katt, W. P., Lukey, M. J., & Cerione, R. A. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0190 · Cited by 179 · see citing works

PET Imaging of Glutaminolysis in Tumors by 18 F-( 2S,4R )4-Fluoroglutamine

Lieberman, B. P., Plöessl, K., Wang, L., Qü, W., Zha, Z., Wise, D. R., Chodosh, L. A., Belka, G. K., Thompson, C. B., & Kung, H. F. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093815 · Cited by 176 · see citing works

Glutamine Metabolism in Sepsis and Infection

Karinch, A. M., Pan, M., Lin, C., Strange, R., & Souba, W. W. (2001) · Journal of Nutrition · doi:10.1093/jn/131.9.2535s · Cited by 173 · see citing works

SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer

Lü, W., Zuo, Y., Feng, Y., & Zhang, M. (2014) · Tumor Biology · doi:10.1007/s13277-014-2372-4 · Cited by 172 · see citing works

Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells

Colombo, S. L., Palacios‐Callender, M., Frakich, N., Carcamo, S., Kovacs, I., Tudzarova, S., & Moncada, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117500108 · Cited by 171 · see citing works

Identification of two human glutaminase loci and tissue-specific expression of the two related genes

Aledo, J. C., GÓMEZ-FABRE, P. M., Olalla, L., & Márquez, J. (2000) · Mammalian Genome · doi:10.1007/s003350010190 · Cited by 160 · see citing works

Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor

DeLaBarre, B., Größ, S., Fang, C., Gao, Y., Jha, A., Jiang, F., Juanhua Song, J., Wei, W., & Hurov, J. (2011) · Biochemistry · doi:10.1021/bi201613d · Cited by 159 · see citing works

Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer

Momcilovic, M., Bailey, S. T., Lee, J. T., Fishbein, M. C., Magyar, C., Braas, D., Graeber, T., Jackson, N. J., Czernin, J., Emberley, E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.061 · Cited by 157 · see citing works

Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations

Emadi, A., Jun, S. A., Tsukamoto, T., Fathi, A. T., Minden, M. D., & Dang, C. V. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.12.001 · Cited by 152 · see citing works

Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells

LOBO, C., RUIZ-BELLIDO, M. A., ALEDO, J. C., MÁRQUEZ, J., NÚÑEZ DE CASTRO, I., & ALONSO, F. J. (2000) · Biochemical Journal · doi:10.1042/bj3480257 · Cited by 151 · see citing works

Therapeutic Strategies Impacting Cancer Cell Glutamine Metabolism

Lukey, M. J., Wilson, K. F., & Cerione, R. A. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.130 · Cited by 151 · see citing works

Glutaminolysis and autophagy in cancer

Villar, V. H., Merhi, F., Djavaheri-Mergny, M., & Durán, R. V. (2015) · Autophagy · doi:10.1080/15548627.2015.1053680 · Cited by 143 · see citing works

Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells

Lora, J., Alonso, F. J., Segura, J. A., Lobo, C., Márquez, J., & Matés, J. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04370.x · Cited by 134 · see citing works

Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma

Gatto, F., Nookaew, I., & Nielsen, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319196111 · Cited by 132 · see citing works

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

Tang, S.-W., Chang, W.-H., Su, Y.-C., Chen, Y., Lai, Y.-H., Wu, P.-T., Hsu, C., Lin, W., Lai, M., & Lin, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.038 · Cited by 131 · see citing works

Glutaminase regulation in cancer cells: a druggable chain of events

Katt, W. P., & Cerione, R. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.008 · Cited by 130 · see citing works

Exploratory Clinical Trial of (4 S )-4-(3-[18F]fluoropropyl)- l -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer

Baek, S., Choi, C., Ahn, S. H., Lee, J. W., Gong, G., Ryu, J., Oh, S. J., Bacher-Stier, C., Fels, L., Koglin, N., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0214 · Cited by 130 · see citing works

The NF-κB member p65 controls glutamine metabolism through miR-23a

Rathore, M. G., Saumet, A., Rossi, J.-F., de Bettignies, C., Tempé, D., Lecellier, C.-H., & Villalba, M. (2012) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/j.biocel.2012.05.011 · Cited by 129 · see citing works

Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes

Colombo, S. L., Palacios‐Callender, M., Frakich, N., de León, J., Schmitt, C. A., Boorn, L., Davis, N., & Moncada, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012362107 · Cited by 126 · see citing works

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

Thompson, R. M., Dytfeld, D., Reyes, L., Robinson, R. M., Smith, B. M., Manevich, Y., Jakubowiak, A. J., Komarnicki, M. A., Przybyłowicz-Chalecka, A., Szczepaniak, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16262 · Cited by 126 · see citing works

Specific PET imaging of xC- transporter activity using a 18F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism

Koglin, N., Mueller, A., Berndt, M., Schmitt-Willich, H., Toschi, L., Stephens, A. W., Gekeler, V., Friebe, M., & Dinkelborg, L. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0687 · Cited by 120 · see citing works

Asparaginases: biochemical pharmacology and modes of drug resistance.

Avramis, V. I. (2012) · PubMed · Cited by 115 · see citing works

Grade-dependent Proteomics Characterization of Kidney Cancer

Perroud, B., Ishimaru, T., Borowsky, A. D., & Weiss, R. H. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800252-mcp200 · Cited by 113 · see citing works

The proportionality of glutaminase content to growth rate and morphology of rat neoplasms.

Knox, W. E., Horowitz, M. L., & Friedell, G. H. (1969) · PubMed · Cited by 112 · see citing works

Glutaminase activities and growth rates of rat hepatomas.

Linder-Horowitz, M., Knox, W. E., & Hp, M. (1969) · PubMed · Cited by 111 · see citing works

Stressing Out Over Survival: Glutamine as an Apoptotic Modulator

Fuchs, B. C., & Bode, B. P. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2005.07.013 · Cited by 111 · see citing works

Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism

O′Flaherty, L., Adam, J., Heather, L. C., Zhdanov, A. V., Chung, Y., Miranda, M. X., Croft, J., Olpin, S. E., Clarke, K. J., Pugh, C. W., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq305 · Cited by 108 · see citing works

Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers

Okazaki, A., Gameiro, P. A., Christodoulou, D. C., Laviolette, L. A., Schneider, M., Chaves, F. L., Stemmer-Rachamimov, A. O., Yazinski, S. A., Lee, R. E., Jr., Stephanopoulos, G. N., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87800 · Cited by 108 · see citing works

Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging

Aboud, O. A., Habib, S. L., Trott, J. F., Stewart, B. J., Liang, S., Chaudhari, A. J., Sutcliffe-Goulden, J., & Weiss, R. H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0930 · Cited by 106 · see citing works

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens

Fan, A. C., Deb-Basu, D., Orban, M. W., Gotlib, J. R., Natkunam, Y., O’Neill, R. A., Padua, R. A., Xu, L., Taketa, D. A., Shirer, A. E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1903 · Cited by 105 · see citing works

Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies

Xiao, Y., & Meierhofer, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153672 · Cited by 101 · see citing works

Dibenzophenanthridines as Inhibitors of Glutaminase C and Cancer Cell Proliferation

Katt, W. P., Ramachandran, S., Erickson, J. W., & Cerione, R. A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0942 · Cited by 100 · see citing works

[18F](2 S ,4 R )4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition

Zhou, R., Pantel, A. R., Li, S., Lieberman, B. P., Plöessl, K., Choi, H., Blankemeyer, E. R., Lee, H. S., Kung, H. F., Mach, R. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1945 · Cited by 99 · see citing works

Altered glutamine metabolism in platinum resistant ovarian cancer

Hudson, C. D., Savadelis, A., Nagaraj, A. B., Joseph, P. L., Avril, S., DiFeo, A. V., & Avril, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.9317 · Cited by 95 · see citing works

Isolation, characterization, and in vitro expression of a cDNA that encodes the kidney isoenzyme of the mitochondrial glutaminase.

Shapiro, R. A., Farrell, L. E., Srinivasan, M., & Curthoys, N. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55132-2 · Cited by 94 · see citing works

Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase

GÓMEZ-FABRE, P. M., Aledo, J. C., CASTILLO-OLIVARES, A. D., Alonso, F. J., de Castro, I. N., Campos-Sandoval, J. A., & Márquez, J. (2000) · Biochemical Journal · doi:10.1042/bj3450365 · Cited by 93 · see citing works

Erratum: From Krebs to clinic: glutamine metabolism to cancer therapy

Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.131 · Cited by 92 · see citing works

Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin

Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Oliveira, E. D., Kamphorst, J. J., Rabinowitz, J. D., Tejero, H., Al‐Shahrour, F., Hidalgo, M. M., Maitra, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1115 · Cited by 90 · see citing works

Expression of glutaminase is upregulated in colorectal cancer and of clinical significance.

(2014) · Europe PMC (PubMed Central) · Cited by 89 · see citing works

Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression

Klomp, J. A., Petillo, D., Niemi, N. M., Dykema, K. J., Chen, J., Yang, X. J., Sääf, A. M., Zickert, P., Aly, M., Bergerheim, U. S. R., et al. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-59 · Cited by 89 · see citing works

Active Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric Inhibitor

Ferreira, A. P. S., Cassago, A., Gonçalves, K. D. A., Dias, M. M., Adamóski, D., Ascenção, C. F. R., Honorato, R. V., de Oliveira, J. F., Ferreira, I. M., Fornezari, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.501346 · Cited by 88 · see citing works

ErbB2 Activation Upregulates Glutaminase 1 Expression Which Promotes Breast Cancer Cell Proliferation

Qie, S., Chu, C., Li, W., Wang, C., & Sang, N. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24684 · Cited by 87 · see citing works

Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells

Stalnecker, C. A., Ulrich, S. M., Li, Y., Ramachandran, S., McBrayer, M. K., DeBerardinis, R. J., Cerione, R. A., & Erickson, J. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414056112 · Cited by 87 · see citing works

A proposed role for glutamine in cancer cell growth through acid resistance

Huang, W., Choi, W.-Y., Chen, Y., Zhang, Q., Deng, H., He, W. A., & Shi, Y. (2013) · Cell Research · doi:10.1038/cr.2013.15 · Cited by 85 · see citing works

Patient-derived xenografts as in vivo models for research in urological malignancies

Inoue, T., Terada, N., Kobayashi, T., & Ogawa, O. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.19 · Cited by 84 · see citing works

Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype

Simpson, N. E., Tryndyak, V., Pogribna, M., Beland, F. A., & Pogribny, I. P. (2012) · Epigenetics · doi:10.4161/epi.22713 · Cited by 83 · see citing works

Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism

Huang, Q., Stalnecker, C. A., Zhang, C., McDermott, L. A., Iyer, P. C., O’Neill, J., Reimer, S., Cerione, R. A., & Katt, W. P. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.810101 · Cited by 83 · see citing works

Novel drugs that target the metabolic reprogramming in renal cell cancer

van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 81 · see citing works

Metabolism of Kidney Cancer: From the Lab to Clinical Practice

Sudarshan, S., Karam, J. A., Brugarolas, J., Thompson, R. H., Uzzo, R. G., Rini, B. I., Margulis, V., Patard, J., Escudier, B. J., & Linehan, W. M. (2012) · European Urology · doi:10.1016/j.eururo.2012.09.054 · Cited by 79 · see citing works

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients

Liu, S., Tian, Z., Zhang, L., Hou, S., Hu, S., Wu, J., Jing, Y., Sun, H., Yu, F., Zhao, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10979 · Cited by 76 · see citing works

Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas

Turner, A., & McGivan, J. D. (2003) · Biochemical Journal · doi:10.1042/bj20021360 · Cited by 73 · see citing works

Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells

Lee, Y., Yang, C., Chang, H.-Y., Hsu, H., Chen, I.-S., Chang, H.-S., Lee, C., Lee, J., Kumar, C. R., Qiu, Y., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2173 · Cited by 73 · see citing works

Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma.

Matsuno, T., & Goto, I. (1992) · PubMed · Cited by 71 · see citing works

Network-based metabolic characterization of renal cell carcinoma

Pandey, N., Lanke, V., & Vinod, P. K. U. (2020) · Scientific Reports · doi:10.1038/s41598-020-62853-8 · Cited by 71 · see citing works

Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation.

Drabkin, H. A., Bradley, C. M., Hart, I. M., Bleskan, J. H., Li, F. P., & Patterson, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.6980 · Cited by 70 · see citing works

Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors

Okegawa, T., Morimoto, M., Nishizawa, S., Kitazawa, S., Honda, K., Araki, H., Tamura, T., Ando, A., Satomi, Y., Nutahara, K., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.009 · Cited by 69 · see citing works

Design and evaluation of novel glutaminase inhibitors

McDermott, L. A., Iyer, P. C., Vernetti, L., Rimer, S., Sun, J., Boby, M. L., Yang, T., Fioravanti, M., O’Neill, J., Wang, L., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.009 · Cited by 68 · see citing works

(4S)-4-(3-18F-Fluoropropyl)-l-Glutamate for Imaging of xC¯ Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies

Baek, S., Mueller, A., Lim, Y., Lee, H. C., Lee, Y. J., Gong, G., Kim, J. S., Ryu, J., Oh, S. J., Lee, S. J., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.108704 · Cited by 66 · see citing works

A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer

Yang, Y., Valera, V., Sourbier, C., Vocke, C. D., Wei, M., Pike, L., Huang, Y. K., Merino, M. A., Bratslavsky, G., Wu, M., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.05.001 · Cited by 65 · see citing works

Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels

Buschdorf, J. P., Chew, L. L., Zhang, B., Cao, Q., Liang, F., Liou, Y., Zhou, Y., & Low, B. C. (2006) · Journal of Cell Science · doi:10.1242/jcs.03061 · Cited by 62 · see citing works

Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies

Mittra, E., Koglin, N., Mosci, C., Kumar, M., Höhne, A., Keu, K. V., Iagaru, A. H., Mueller, A., Berndt, M., Bullich, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148628 · Cited by 56 · see citing works

Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating

Michalopoulou, E., Bulusu, V., & Kamphorst, J. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.256 · Cited by 55 · see citing works

A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway

Han, T., Guo, M., Zhang, T., Gan, M., Xie, C., & Wang, J.-B. (2016) · Oncotarget · doi:10.18632/oncotarget.14188 · Cited by 55 · see citing works

Phosphate‐activated glutaminase expression during tumor development

Aledo, J. C., Segura, J. A., Medina, M. Á., Alonso, F. J., de Castro, I. N., & Márquez, J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80236-x · Cited by 54 · see citing works

Interferon-α Regulates Glutaminase 1 Promoter through STAT1 Phosphorylation: Relevance to HIV-1 Associated Neurocognitive Disorders

Zhao, L., Huang, Y., Tian, C., Taylor, L., Curthoys, N. P., Wang, Y., Vernon, H., & Zheng, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032995 · Cited by 53 · see citing works

Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na

Seetharam, M., Fan, A. C., Tran, M., Xu, L., Renschler, J. P., Felsher, D. W., Sridhar, K. J., Wilhelm, F. E., & Greenberg, P. L. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.08.022 · Cited by 53 · see citing works

Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma

Elson, P. J., Kvols, L. K., Vogl, S. E., Glover, D. J., Hahn, R. G., Trump, D. L., Carbone, P. P., Earle, J. D., & Davis, T. E. (1988) · Investigational New Drugs · doi:10.1007/bf00195367 · Cited by 53 · see citing works

Utility of [18F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population

Kavanaugh, G. M., Williams, J., Morris, A., Nickels, M. L., Walker, R. C., Koglin, N., Stephens, A. W., Washington, M. K., Geevarghese, S. K., Liu, Q., et al. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-1007-0 · Cited by 52 · see citing works

Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer

Hassanein, M., Hight, M. R., Buck, J. R., Tantawy, M. N., Nickels, M. L., Hoeksema, M. D., Harris, B. K., Boyd, K. L., Massion, P. P., & Manning, H. C. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0862-4 · Cited by 50 · see citing works

Relative Expression of mRNAS Coding for Glutaminase Isoforms in CNS Tissues and CNS Tumors

Szeliga, M., Matyja, E., Obara‐Michlewska, M., Grajkowska, W., Czernicki, T., & Albrecht, J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9507-6 · Cited by 50 · see citing works

A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors

Mueller, C., Al-Batran, S. E., Jaeger, E., Schmidt, B., Bausch, M., Unger, C., & Sethuraman, N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2533 · Cited by 49 · see citing works

Structural basis for exploring the allosteric inhibition of human kidney type glutaminase

Ramachandran, S., Pan, C. Q., Zimmermann, S. C., Duvall, B. R., Tsukamoto, T., Low, B. C., & Sivaraman, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10791 · Cited by 48 · see citing works

Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer

Xie, C., Jin, J., Bao, X., Zhan, W.-H., Han, T.-Y., Gan, M., Zhang, C., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.6311 · Cited by 47 · see citing works

BPTES inhibition of hGA124–551, a truncated form of human kidney-type glutaminase

Hartwick, E. W., & Curthoys, N. P. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.622272 · Cited by 46 · see citing works

Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts

Ingels, A., Zhao, H., Thong, A. E. C., Saar, M., Valta, M. P., Nolley, R., Santos, J., & Peehl, D. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28579 · Cited by 44 · see citing works

Diphenylarsinic Acid Promotes Degradation of Glutaminase C by Mitochondrial Lon Protease

Kita, K., Suzuki, T., & Ochi, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362699 · Cited by 44 · see citing works

Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool

Dahlmanns, M., Yakubov, E., Chen, D., Sehm, T., Rauh, M., Savaskan, N. E., & Dahlmanns, J. K. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.30 · Cited by 43 · see citing works

Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition

Martinez Marignac, V., & Richard, S. (2015) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.157317 · Cited by 42 · see citing works

Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma

Sanders, E. B., & Diehl, S. (2015) · Oncoscience · doi:10.18632/oncoscience.128 · Cited by 42 · see citing works

Tissue slice grafts of human renal cell carcinoma: An authentic preclinical model with high engraftment rate and metastatic potential

Thong, A. E. C., Zhao, H., Ingels, A., Valta, M. P., Nolley, R., Santos, J., Young, S. R., & Peehl, D. M. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.05.008 · Cited by 41 · see citing works

The 3'-nontranslated region of rat renal glutaminase mRNA contains a pH-responsive stability element

Hansen, W. R., Barsic-Tress, N., Taylor, L. E., & Curthoys, N. P. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.271.1.f126 · Cited by 39 · see citing works

“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced LymphomaIn Vivo

DeChristopher, B. A., Fan, A. C., Felsher, D. W., & Wender, P. A. (2012) · Oncotarget · doi:10.18632/oncotarget.438 · Cited by 35 · see citing works

Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation

Zhao, H., Nolley, R., Chan, A., Rankin, E. B., & Peehl, D. M. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1219816 · Cited by 34 · see citing works

Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer

Grkovski, M., Goel, R., Krebs, S. S., Staton, K. D., Harding, J. J., Mellinghoff, I. K., Humm, J. L., & Dunphy, M. P. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.229740 · Cited by 34 · see citing works

Analyses of the Transcriptome and Metabolome Demonstrate That HIF1α Mediates Altered Tumor Metabolism in Clear Cell Renal Cell Carcinoma

Minton, D. R., Fu, L., Chen, Q., Robinson, B. D., Gross, S. S., Nanus, D. M., & Gudas, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120649 · Cited by 31 · see citing works

Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells

Thorén, M. M., Vaapil, M., Staaf, J., Planck, M., Johansson, M. E., Mohlin, S., & Påhlman, S. (2017) · Oncotarget · doi:10.18632/oncotarget.16904 · Cited by 31 · see citing works

Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies

Rathmell, K., Chen, F.-J., & Creighton, C. (2015) · Oncoscience · doi:10.18632/oncoscience.130 · Cited by 29 · see citing works

Glutamine synthetase and glutaminase activities in various hepatoma cells.

Matsuno, T., & Hirai, H. (1989) · PubMed · Cited by 29 · see citing works

Effect of anaerobiosis and addition of keto acids on glutamine utilization by Ehrlich ascites-tumor cells

Kvamme, E., & Svenneby, G. (1960) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(60)90779-4 · Cited by 26 · see citing works

Metabolomic characterisation of the effects of oncogenic PIK3CA transformation in a breast epithelial cell line

Lau, C. E., Tredwell, G. D., Ellis, J. K., Lam, E. W. ‐., & Keun, H. C. (2017) · Scientific Reports · doi:10.1038/srep46079 · Cited by 26 · see citing works

Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication

Park, S., Ha, S., Kwon, H. W., Kim, W. H., Kim, T., Oh, D., Cheon, G. J., & Bang, Y. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.182675 · Cited by 25 · see citing works

First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options

Loo, V., Salgia, M. M., Bergerot, P. G., Philip, E. J., & Pal, S. K. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00676-y · Cited by 24 · see citing works

Development of a realistic in vivo bone metastasis model of human renal cell carcinoma

Valta, M. P., Zhao, H., Ingels, A., Thong, A. E. C., Nolley, R., Saar, M., & Peehl, D. M. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9651-8 · Cited by 20 · see citing works

Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation

Sontakke, P., Koczula, K. M., Jaques, J., Wierenga, A. T. J., Brouwers-Vos, A. Z., Pruis, M. G. M., Günther, U. L., Vellenga, E., & Schuringa, J. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153226 · Cited by 19 · see citing works

Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma

Ye, X., Zhou, Q., Matsumoto, Y., Moriyama, M., Kageyama, S., Komatsu, M., Satoh, S., Tsuchida, M., & Saijo, Y. (2016) · Anticancer Research · doi:10.21873/anticanres.11191 · Cited by 14 · see citing works

Bmcc1s interacts with the phosphate-activated glutaminase in the brain

Boulay, A.-C., Burbassi, S., Lorenzo, H. K., Loew, D., Ezan, P., Giaume, C., & Cohen‐Salmon, M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.11.016 · Cited by 13 · see citing works

Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer

Fan, A. C., O'Rourke, J., Praharaj, D. R., & Felsher, D. W. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.829453 · Cited by 12 · see citing works

Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)

Meric‐Bernstam, F., Tannir, N. M., Harding, J. J., Voss, M. J., Mier, J. W., DeMichele, A., Münster, P. N., Patel, M., Iliopoulos, O., Owonikoko, T. K., et al. (2016) · European Journal of Cancer · doi:10.1016/s0959-8049(16)32626-0 · Cited by 10 · see citing works

Glutamine reliance in cell metabolism

Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental &amp; Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works

The Diverse Functions of Non-Essential Amino Acids in Cancer

Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213 · see citing works

Metabolic reprogramming in renal cancer: Events of a metabolic disease

Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 208 · see citing works

The role of glutaminase in cancer

Masisi, B. K., Ansari, R. E., Alfarsi, L. H., Rakha, E. A., Green, A. R., & Craze, M. L. (2019) · Histopathology · doi:10.1111/his.14014 · Cited by 169 · see citing works

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159 · see citing works

Clinical development of metabolic inhibitors for oncology

Lemberg, K. M., Gori, S. S., Tsukamoto, T., Rais, R., & Slusher, B. S. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148550 · Cited by 142 · see citing works

Metabolic reprogramming and the role of mitochondria in polycystic kidney disease

Podrini, C., Cassina, L., & Boletta, A. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109495 · Cited by 123 · see citing works

Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies

Xiao, Y., & Meierhofer, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153672 · Cited by 101 · see citing works

PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis

Bădoiu, S. C., Greabu, M., Miricescu, D., Stănescu-Spînu, I.-I., Ilinca, R., Bălan, D. G., Balcangiu‐Stroescu, A.-E., Mihai, D. A., Văcăroiu, I. A., Ștefani, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098391 · Cited by 99 · see citing works

Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer

Aggarwal, R. K., Luchtel, R. A., Machha, V. R., Tischer, A., Zou, Y., Pradhan, K., Ashai, N., Ramachandra, N., Albanese, J. M., Yang, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106947118 · Cited by 92 · see citing works

GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors

Li, Y., Li, B., Xu, Y., Qian, L., Xu, T., Meng, G., Li, H., Wang, Y., Zhang, L., Jiang, X. W., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0042 · Cited by 88 · see citing works

Network-based metabolic characterization of renal cell carcinoma

Pandey, N., Lanke, V., & Vinod, P. K. U. (2020) · Scientific Reports · doi:10.1038/s41598-020-62853-8 · Cited by 71 · see citing works

Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Meric‐Bernstam, F., Tannir, N. M., Iliopoulos, O., Lee, R. J., Telli, M. L., Fan, A. C., DeMichele, A. M., Haas, N. B., Patel, M. R., Harding, J. J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2972 · Cited by 67 · see citing works

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma

Emberley, E. D., Pan, A., Chen, J., Dang, R., Gross, M. I., Huang, T. C., Li, W., MacKinnon, A. L., Singh, D., Sotirovska, N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259241 · Cited by 53 · see citing works

Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma

Bacigalupa, Z. A., & Rathmell, W. K. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.034 · Cited by 45 · see citing works

A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer

Wang, J., Siu, M. K.-Y., Jiang, Y., Leung, T. H.-Y., Chan, D. W., Wang, H., Ngan, H., & Chan, K. K. L. (2021) · Biomolecules · doi:10.3390/biom11121749 · Cited by 45 · see citing works

Potential New Therapeutic Approaches for Renal Cell Carcinoma

Yang, D. C. H., & Chen, C. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.12.010 · Cited by 41 · see citing works

Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment

Fan, Y., Xue, H., Li, Z., Huo, M., Gao, H., & Guan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1345522 · Cited by 40 · see citing works

Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma

Sato, T., Kawasaki, Y., Maekawa, M., Takasaki, S., Morozumi, K., Sato, M., Shimada, S., Kawamorita, N., Yamashita, S., Mitsuzuka, K., et al. (2020) · Metabolites · doi:10.3390/metabo11010001 · Cited by 41 · see citing works

The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy

Xie, D., Li, G., Zheng, Z., Zhang, X., Wang, S., Jiang, B., Li, X., Wang, X., & Wu, G. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101335 · Cited by 38 · see citing works

Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy

Jeda, A. S., Ghabeshi, S., pour, Z. G. M., Jazaeri, E. O., Araiinejad, M., Sheikholeslami, F., Abdoli, M., Edalat, M., & Abdoli, A. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100512 · Cited by 37 · see citing works

Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma

Ziki, R. A., & Colnot, S. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101077 · Cited by 35 · see citing works

Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer

Grkovski, M., Goel, R., Krebs, S. S., Staton, K. D., Harding, J. J., Mellinghoff, I. K., Humm, J. L., & Dunphy, M. P. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.229740 · Cited by 34 · see citing works

PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer

Zhu, H., Du, C., Yuan, M., Fu, P., He, Q., Yang, B., & Cao, J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.006 · Cited by 34 · see citing works

Prostate cancer cells survive anti‐androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities

Basu, H. S., Wilganowski, N. L., Robertson, S., Reuben, J. M., Cohen, E. N., Zurita, A. J., Ramachandran, S., Xiao, L., Titus, M. A., & Wilding, G. (2021) · The Prostate · doi:10.1002/pros.24146 · Cited by 33 · see citing works

The metabolic landscape of urological cancers: New therapeutic perspectives

Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., Baltazar, F., & Jerónimo, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.034 · Cited by 32 · see citing works

The Role of Metabolic Factors in Renal Cancers

Rysz, J., Franczyk, B., Ławiński, J., Olszewski, R., & Gluba-Brzózka, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197246 · Cited by 30 · see citing works

Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor “CFIm25”

Tamaddon, M., Shokri, G., Hosseini Rad, S. M. A., Rad, I., Emami Razavi, À., & Kouhkan, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-68406-3 · Cited by 25 · see citing works

Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery

Giesen, B., Nickel, A., Barthel, J., Kahlert, U. D., & Janiak, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020295 · Cited by 25 · see citing works

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials

Zhuang, T., Case, K. B., Olsen, T. A., Brown, J. T., Carthon, B. C., Küçük, Ö., Goldman, J. M., Harris, W. B., Bilen, M. A., & Nazha, B. (2022) · Cancers · doi:10.3390/cancers14122867 · Cited by 25 · see citing works

First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options

Loo, V., Salgia, M. M., Bergerot, P. G., Philip, E. J., & Pal, S. K. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00676-y · Cited by 24 · see citing works

Dietary Manipulation of Amino Acids for Cancer Therapy

Jiménez‐Alonso, J. J., & López‐Lázaro, M. (2023) · Nutrients · doi:10.3390/nu15132879 · Cited by 24 · see citing works

Bioinspired nanocatalytic tumor therapy by simultaneous reactive oxygen species generation enhancement and glutamine pathway-mediated glutathione depletion

Mao, H., Wen, Y., Yu, Y., Li, H., Wang, J., & Sun, B. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb02194c · Cited by 23 · see citing works

The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective

Kim, I.-H., & Lee, H. J. (2022) · Biomedicines · doi:10.3390/biomedicines10020251 · Cited by 22 · see citing works

Targeting the Metabolic Adaptation of Metastatic Cancer

Tarragó‐Celada, J., & Cascante, M. (2021) · Cancers · doi:10.3390/cancers13071641 · Cited by 20 · see citing works

18F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models

Zhou, R., Choi, H., Cao, J., Pantel, A. R., Gupta, M., Lee, H. S., & Mankoff, D. A. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264152 · Cited by 17 · see citing works

Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma

Calderón‐Montaño, J. M., Guillén-Mancina, E., Jiménez‐Alonso, J. J., Jiménez-González, V., Burgos‐Morón, E., Mate, A., Pérez-Guerrero, M. C., & López‐Lázaro, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416132 · Cited by 14 · see citing works

The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer

Vadlakonda, L., Indracanti, M., Kalangi, S. K., Gayatri, B. M., Gajula, N. N., & Reddy, A. B. M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00566-5 · Cited by 11 · see citing works

Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas

Choe, J. H., Mazambani, S., Kim, T. H., & Kim, J. (2021) · Cells · doi:10.3390/cells10030606 · Cited by 13 · see citing works

Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma

Ene, C. D., Tampa, M. Ş., Georgescu, S. R., Matei, C., Leulescu, I. M. T., Dogaru, C. I., Penescu, M. N., & Nicolae, I. (2023) · Cancers · doi:10.3390/cancers15245797 · Cited by 10 · see citing works

Targeting Metabolic Pathways in Kidney Cancer

Hoerner, C. R., Miao, S. Y., Hsieh, J. J.-D., & Fan, A. C. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000472 · Cited by 9 · see citing works

Metabolomics Reveals Tyrosine Kinase Inhibitor Resistance-Associated Metabolic Events in Human Metastatic Renal Cancer Cells

Amaro, F., Carvalho, M. C., Bastos, M. D. L., de Pinho, P. G., & Pinto, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126328 · Cited by 7 · see citing works

Contribution and Expression of Organic Cation Transporters and Aquaporin Water Channels in Renal Cancer

Ciarimboli, G., Theil, G., Białek, J., & Edemir, B. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_34 · Cited by 7 · see citing works

Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo

Zacharias, N. M., Wang, L., Maity, T., Li, L., Millward, S. W., Karam, J. A., Wood, C. G., & Navai, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062849 · Cited by 7 · see citing works

Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics

Krencz, I., Vetlényi, E., Dankó, T., Petővári, G., Moldvai, D., Sztankovics, D., Raffay, R. E., Mészáros, K. V., Sebestyén, E., Végső, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810587 · Cited by 7 · see citing works

Characterization of the metabolomic profile of renal cell carcinoma by high resolution magic angle spinning proton magnetic resonance spectroscopy

Huynh, M. J., Gusev, A., Palmas, F., Vandergrift, L. A., Berker, Y., Wu, C., Wu, S., Cheng, L. L., & Feldman, A. S. (2023) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2023.09.005 · Cited by 6 · see citing works

α-Ketoglutaramate—A key metabolite contributing to glutamine addiction in cancer cells

Cooper, A. J. L., Dorai, T., Pinto, J. T., & Denton, T. T. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1035335 · Cited by 5 · see citing works

Manipulation of Amino Acid Levels With Artificial Diets Induces Anticancer Activity in Mice With Renal Cell CarcinomaPreprint

Calderón‐Montaño, J. M., Guillén-Mancina, E., Jiménez‐Alonso, J. J., Jiménez-González, V., Burgos‐Morón, E., Mate, A., Pérez-Guerrero, M. C., & López‐Lázaro, M. (2022) · Preprints.org · doi:10.20944/preprints202208.0088.v1 · Cited by 5 · see citing works

AGC1-mediated Metabolic Reprogramming and Autophagy Sustain Survival of Hepatocellular Carcinoma Cells under Glutamine Deprivation

Liu, Y., Miao, Z., & Yang, Q. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01311-y · Cited by 5 · see citing works

Overview of glutamine metabolism in stromal components of the tumor microenvironment and potential anti-tumor therapies

Li, Z., Deng, J., Wang, H., Liu, T., Zhou, Y., Ouyang, P., Liang, X., Zhang, X., Qi, S., & Li, Y. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101834 · Cited by 3 · see citing works

Multi-Omics Approach Reveals Redox Homeostasis Reprogramming in Early-Stage Clear Cell Renal Cell Carcinoma

Zhang, W., Qiao, X., Xie, T., Cai, W., Zhang, X., Chen, C., & Zhang, Y. (2022) · Antioxidants · doi:10.3390/antiox12010081 · Cited by 3 · see citing works

Glucose deprivation impairs hypoxia-inducible factor-1α synthesis

Hubert, M., Stuart, S. E., & Ohh, M. (2024) · Discover Oncology · doi:10.1007/s12672-024-01484-1 · Cited by 3 · see citing works

Hybrid Metabolic Activity-Related Prognostic Model and Its Effect on Tumor in Renal Cell Carcinoma

Yu, L., Ding, L., Wang, Z.-Y., Zhao, X.-Z., Wang, Y.-H., Liang, C., & Li, J. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/1147545 · Cited by 2 · see citing works

Mechanism of action of photobiomodulation with light‐emitting diode on the glutamine‐dependent CT26 cell

Hu, S., & Liu, T. C. (2023) · Journal of Biophotonics · doi:10.1002/jbio.202300353 · Cited by 2 · see citing works

Influence of Dietary Polyunsaturated Fatty Acid Intake on Potential Lipid Metabolite Diagnostic Markers in Renal Cell Carcinoma: A Case-Control Study

Kim, Y.-H., Chung, J., Lee, H. H., Park, J., & Kim, M. K. (2024) · Nutrients · doi:10.3390/nu16091265 · Cited by 3 · see citing works

Metabolic Reprogramming in Renal Cell Carcinoma: A Scoping Review with Quantitative Integration of Metabolomic Studies

Amaro, F., Carvalho, M. C., Bastos, M. D. L., de Pinho, P. G., & Pinto, J. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6c00079 · Cited by 1 · see citing works

Novel Targets in Development for Advanced Renal Cell Carcinoma

Thapa, B., Nelson, A. A., & Kilari, D. (2023) · Springer eBooks · doi:10.1007/978-3-031-40901-1_14 · Cited by 1 · see citing works

Characterization of a fluorescence imaging probe that exploits metabolic dependency of ovarian clear cell carcinoma

Tsuchimochi, S., Wada‐Hiraike, O., Urano, Y., Kukita, A., Yamaguchi, K., Honjo, H., Taguchi, A., Tanikawa, M., Sone, K., Mori‐Uchino, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47637-0 · Cited by 1 · see citing works

Novel molecular targets in hepatic stellate cells for the treatment of liver fibrosis

Smith‐Cortinez, N. (2020) · doi:10.33612/diss.128130988 · Cited by 1 · see citing works

Loss of GLS2 function is essential for obtaining oncogenic functions and promotes the progression of clear cell renal cell carcinoma.Preprint

Sun, D., Tian, L., Zhao, H., Yan, W., Wei, X., Wo, Y., & Hou, H. (2020) · doi:10.21203/rs.2.23360/v1 · Cited by 1 · see citing works

Tumor starvation by deprivation of glutamine and aspartate

Fried, R., Carlton, R. M., & Fried, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824013-7.00008-0

Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Meric‐Bernstam, F., Tannir, N. M., Iliopoulos, O., Lee, R. J., Telli, M. L., Fan, A. C., DeMichele, A. M., Haas, N. B., Patel, M. R., Harding, J. J., et al. (2023) · doi:10.1158/1078-0432.c.6532368.v1

Oncoaddictology: Glucose and Glutamine Addiction in Cancer

Nagy, M. A. (2023) · International Journal of Clinical Case Reports and Reviews · doi:10.31579/2690-4861/325

Olaparib targets Ubiquitin D to promote autophagy in hepatocellular carcinoma by regulating glutamine metabolism

Zhu, W., Zhang, F., Qu, H., Li, N., Chen, X., & Tu, W. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2586736

Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment

Abdullah, H., Zhang, Y., Kirkwood, K. J., Laird, A., Mullen, P., Harrison, D. J., & Elshani, M. (2026) · Cancers · doi:10.3390/cancers18020254

Anticancer Potential of Cannabidiol in Renal Cell Carcinoma: Serum Modulation and Preliminary Mechanistic Insights

Sousa, D., Amaro, F., Araújo, A. M., & Carvalho, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020792

Glutamine Starvation Induces Ferroptosis in NSCLC via AMPK/PDZD8-Mediated Ferritinophagy

Chen, H., Wu, X., Zhu, M., Cheng, Y., & Feng, Q. (2026) · Nutrients · doi:10.3390/nu18101596

Monocarboxylate transporters in physiology and cancer: from fundamentals to clinical translation

Afonso, J., Pereira-Vieira, J., Miranda‐Gonçalves, V., Granja, S., Pinheiro, C. M., & Baltazar, F. (2026) · Physiological Reviews · doi:10.1152/physrev.00004.2026

In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma

Kaushik, A., Tarangelo, A., Boroughs, L. K., Ragavan, M., Zhang, Y., Wu, C., Li, X., Ahumada, K., Chiang, J., Tcheuyap, V. T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8293 · Cited by 55 · see citing works

Abstract 3972: Novel renal cell carcinoma therapy targeting glutaminolysis

Muto, Y., Takeuchi, A., Zennami, K., Sugihara, E., Shiroki, R., Saya, H., & Sumitomo, M. (2023) · Cancer Research · doi:10.1158/1538-7445.am2023-3972

Glutaminase inhibition in renal cell carcinoma therapy

Raczka, A. M., & Reynolds, P. A. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2018.004 · Cited by 28 · see citing works

Targeting glutamine use in RCC

Wang, M. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00684-2 · Cited by 5 · see citing works

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma

Emberley, E. D., Pan, A., Chen, J., Dang, R., Gross, M. I., Huang, T. C., Li, W., MacKinnon, A. L., Singh, D., Sotirovska, N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259241 · Cited by 53 · see citing works